Document ID: chunk:federal_register_of_legislation:F2025C00183:clause:1_73350
Version: federal_register_of_legislation:F2025C00183
Segment Type: clause
Provision Reference: sch 1 cl 73350
Character Range: 301660–302931

73350              Test of a pregnant patient, for the purpose of determining whether pathogenic cystic fibrosis transmembrane conductance regulator variants are present in the fetus in order to make or exclude a diagnosis of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder in the fetus, if:                                                                                                                                                                                                                                           250.00
                   (a) one or both prospective parents are known to be a genetic carrier of pathogenic cystic fibrosis transmembrane conductance regulator variants; and
                   (b) the fetus is at a risk, of at least 25%, of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder because of known familial cystic fibrosis transmembrane conductance regulator variants; and
                   (c) the test is requested by a specialist or consultant physician who manages the treatment of the patient; and
                   (d) the test is not associated with a service to which item 73346 applies
                   Applicable only once per pregnancy